Get started
Author

D D Bolsun

Observed names: D. D. Bolsun, D.D. Bolsun, D.D. Bolsun Bolsun, Daria Bolsun
Institution: BIOCAD (Russia)
ORCID: 0000-0002-7583-5235
Observed ORCID: 0000-0002-7583-5235
OpenAlex ID: A5086408264
Hepatitis C in the Russian Federation: challenges and future directions
2016 · Galina Trifonova, Irina Levakova, et al. · Hepatic Medicine Evidence and Research · 27
PDF
Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS
2023 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 14
Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2
2023 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 13
Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial
2022 · A.N. Boyko, O.V. Boyko, et al. · S S Korsakov Journal of Neurology and Psychiatry · 10
Epidemiological Features of Hepatitis C Virus Infection in the Russian Federation in 1994–2013
2014 · G. F. Trifonova, I. A. Levakova, et al. · Russian Journal of Infection and Immunity · 10
PDF
Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results
2023 · A.N. Boyko, K.Z. Bakhtiyarova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 4
Sp344the Efficacy and Safety of Bcd-131 in Treatment of Renal Anemia in Chronic Kidney Disease
2019 · Maria Morozova, Daria Bolsun, et al. · Nephrology Dialysis Transplantation · 1
[Frequency of antibodies against surface and nuclear antigens of hepatitis B virus in population of St. Petersburg in 2013].
2014 · S L Mukomolov, D D Bolsun, et al. · PubMed · 1
Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial
2019 · V.IU. Shilo Shilo, L.I. Alihanova Alihanova, et al. · Kliničeskaâ nefrologiâ
Works count: 9
Citation count: 80
H-index: 5
I10-index: 5
Year
Topic
Type